KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares Outstanding
Ratios

Vir Biotechnology (VIR) Shares Outstanding (2018 - 2025)

Vir Biotechnology's Shares Outstanding history spans 8 years, with the latest figure at $139.5 million for Q4 2025.

  • On a quarterly basis, Shares Outstanding rose 1.84% to $139.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $139.5 million, a 1.84% increase, with the full-year FY2025 number at $139.5 million, up 1.84% from a year prior.
  • Shares Outstanding hit $139.5 million in Q4 2025 for Vir Biotechnology, roughly flat from $139.0 million in the prior quarter.
  • Over the last five years, Shares Outstanding for VIR hit a ceiling of $139.5 million in Q4 2025 and a floor of $129.9 million in Q1 2021.
  • Historically, Shares Outstanding has averaged $134.6 million across 5 years, with a median of $134.4 million in 2023.
  • Biggest five-year swings in Shares Outstanding: grew 19.88% in 2021 and later increased 1.11% in 2023.
  • Tracing VIR's Shares Outstanding over 5 years: stood at $131.2 million in 2021, then increased by 1.58% to $133.2 million in 2022, then rose by 1.16% to $134.8 million in 2023, then increased by 1.62% to $137.0 million in 2024, then increased by 1.84% to $139.5 million in 2025.
  • Business Quant data shows Shares Outstanding for VIR at $139.5 million in Q4 2025, $139.0 million in Q3 2025, and $138.9 million in Q2 2025.